Veraxa Biotech Holding AG (CIK 0002079109) (VRXA)
Activity window: Oct. 25, 2025 to Oct. 24, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Feb. 13, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Feb. 13, 2026 | CORRESP | Neutral/Informational | Moderate | Veraxa Biotech AG has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form F-4. The company is seeking to have the registration … | Read Filing EDGAR |
| Feb. 12, 2026 | CORRESP | Neutral/Informational | Moderate | Veraxa Biotech AG has submitted a response to the SEC's comments regarding their Amendment No. 4 to the Registration Statement on Form F-4, which relates to their proposed busines… | Read Filing EDGAR |
| Feb. 11, 2026 | UPLOAD | Concern from SEC | Moderate | The SEC has reviewed the amended registration statement for Veraxa Biotech Holding AG and has issued a comment regarding the risk factors associated with the High Trail Financing … | Read Filing EDGAR |
| Nov. 28, 2025 | CORRESP | Concern from SEC | Moderate | Veraxa Biotech AG has submitted a response to the SEC's comments regarding their Amendment No. 2 to the Registration Statement on Form F-4. The correspondence addresses several sp… | Read Filing EDGAR |
| Nov. 20, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed Veraxa Biotech AG's amended registration statement and issued several comments requiring clarification and revisions. Key concerns include the representation … | Read Filing EDGAR |